Literature DB >> 12438353

Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection.

Ping Zhang1, Christina Jespersgaard, Leticia Lamberty-Mallory, Jannet Katz, Yan Huang, George Hajishengallis, Suzanne M Michalek.   

Abstract

The saliva-binding region (SBR) of the cell surface antigen I/II (AgI/II) and the glucan-binding region (GLU) of the glucosyltransferase enzyme of Streptococcus mutans have been implicated in the initial adherence of S. mutans to saliva-coated tooth surfaces and the subsequent sucrose-dependent accumulation of S. mutans, respectively. Here, we describe the construction and characterization of a genetic chimeric protein consisting of the two virulence determinants SBR and GLU (SBR-GLU). The effectiveness of this construct in inducing mucosal and systemic immune responses to each virulence determinant following intranasal immunization was compared to that of each antigen alone or an equal mixture of SBR and GLU (SBR+GLU) in a mouse model. Furthermore, the ability of antibodies induced to SBR-GLU to protect against S. mutans infection was also investigated. Immunization of mice with the chimeric protein SBR-GLU resulted in significantly enhanced (P < 0.001) levels of serum immunoglobulin G (IgG) anti-SBR antibody activity compared to those in the SBR and SBR+GLU groups. The SBR-GLU-immunized mice also demonstrated a significant (P < 0.05) increase in salivary and vaginal IgA antibody responses to SBR and GLU. Analysis of the serum IgG subclass responses to SBR in mice immunized with SBR alone indicated a mixed IgG1 and IgG2a response. A preferential IgG1 response compared to an IgG2a anti-GLU response was induced in mice immunized with GLU alone. Similarly, a preferential IgG1 response was also induced to SBR when GLU was present in either a mixed or conjugated form. Finally, a significant reduction (P < 0.05) in S. mutans colonization was observed only in mice immunized with the SBR-GLU chimeric protein. Taken together, our results indicate that the chimeric protein SBR-GLU significantly enhanced mucosal immune responses to SBR and GLU and systemic immune responses to SBR. The ability of SBR-GLU to induce responses effective in protection against colonization of S. mutans suggests its potential as a vaccine antigen for dental caries.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438353      PMCID: PMC133010          DOI: 10.1128/IAI.70.12.6779-6787.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 2.  Functional diversity of T lymphocytes due to secretion of different cytokine patterns.

Authors:  N E Street; T R Mosmann
Journal:  FASEB J       Date:  1991-02       Impact factor: 5.191

3.  Size and subdomain architecture of the glucan-binding domain of sucrose:3-alpha-D-glucosyltransferase from Streptococcus sobrinus.

Authors:  C Wong; S A Hefta; R J Paxton; J E Shively; G Mooser
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

4.  Characterisation of antigens extracted from cells and culture fluids of Streptococcus mutans serotype c.

Authors:  M W Russell; T Lehner
Journal:  Arch Oral Biol       Date:  1978       Impact factor: 2.633

5.  Isolation of a glucan-binding domain of glucosyltransferase (1,6-alpha-glucan synthase) from Streptococcus sobrinus.

Authors:  G Mooser; C Wong
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

6.  1984 Kreshover lecture. Genetic analysis of Streptococcus mutans virulence and prospects for an anticaries vaccine.

Authors:  R Curtiss
Journal:  J Dent Res       Date:  1986-08       Impact factor: 6.116

Review 7.  Role of Streptococcus mutans in human dental decay.

Authors:  W J Loesche
Journal:  Microbiol Rev       Date:  1986-12

8.  Passive immunization with milk produced from an immunized cow prevents oral recolonization by Streptococcus mutans.

Authors:  Y Shimazaki; M Mitoma; T Oho; Y Nakano; Y Yamashita; K Okano; Y Nakano; M Fukuyama; N Fujihara; Y Nada; T Koga
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

9.  Effect of attenuated Salmonella enterica serovar Typhimurium expressing a Streptococcus mutans antigen on secondary responses to the cloned protein.

Authors:  C Jespersgaard; P Zhang; G Hajishengallis; M W Russell; S M Michalek
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

10.  Isolation and sequence of an active-site peptide containing a catalytic aspartic acid from two Streptococcus sobrinus alpha-glucosyltransferases.

Authors:  G Mooser; S A Hefta; R J Paxton; J E Shively; T D Lee
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

View more
  22 in total

1.  A therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune response.

Authors:  Rebekah A Robinette; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  Vaccine       Date:  2011-06-23       Impact factor: 3.641

2.  Self-assembling anticaries mucosal vaccine containing ferritin cage nanostructure and glucan-binding region of S. mutans glucosyltransferase effectively prevents caries formation in rodents.

Authors:  Xi-Xi Cao; Yu-Hong Li; Qian-Lin Ye; Xuan Hu; Tian-Feng Wang; Ming-Wen Fan
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

3.  Contribution of a Streptococcus mutans antigen expressed by a Salmonella vector vaccine in dendritic cell activation.

Authors:  Qingan Xu; Jenny Katz; Ping Zhang; Amit R Ashtekar; Dalia E Gaddis; Mingwen Fan; Suzanne M Michalek
Journal:  Infect Immun       Date:  2011-07-11       Impact factor: 3.441

4.  Immunological and protective effects of diepitopic subunit dental caries vaccines.

Authors:  Daniel J Smith; William F King; Joy Rivero; Martin A Taubman
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

5.  Alterations in immunodominance of Streptococcus mutans AgI/II: lessons learned from immunomodulatory antibodies.

Authors:  Rebekah A Robinette; Kyle P Heim; Monika W Oli; Paula J Crowley; William P McArthur; L Jeannine Brady
Journal:  Vaccine       Date:  2013-11-16       Impact factor: 3.641

6.  Characterization of the Streptococcus mutans P1 epitope recognized by immunomodulatory monoclonal antibody 6-11A.

Authors:  Nikki R Rhodin; Jenny M Cutalo; Kenneth B Tomer; William P McArthur; L Jeannine Brady
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  Role of peptide antigen for induction of inhibitory antibodies to Streptococcus mutans in human oral cavity.

Authors:  Y Tsuha; N Hanada; T Asano; T Abei; S Yamaguchi; M A Salam; R Nakao; H Takeuchi; N Kurosaki; H Senpuku
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

8.  Contribution of the alanine-rich region of Streptococcus mutans P1 to antigenicity, surface expression, and interaction with the proline-rich repeat domain.

Authors:  Trevor B Seifert; Arnold S Bleiweis; L Jeannine Brady
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines.

Authors:  Peter T Beernink; Dan M Granoff
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

10.  Beneficial immunomodulation by Streptococcus mutans anti-P1 monoclonal antibodies is Fc independent and correlates with increased exposure of a relevant target epitope.

Authors:  Rebekah A Robinette; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.